Clinical Trials
28 trialsStudy сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
R-Pharm
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma
Biocad
FLAT
Biocad
A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver
Taizhou Hanzhong biomedical co. LTD
LYMbR
Alberta Health Services, Calgary
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
Bispebjerg Hospital
HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
Peking University Cancer Hospital & Institute
High Frequency Jet Ventilation for Percutaneous Interventional Radiology
University Hospital, Strasbourg, France
M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
AVAX Technologies
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
National Cancer Institute (NCI)
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
National Cancer Institute (NCI)
Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
National Cancer Institute (NCI)
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
National Cancer Institute (NCI)
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
National Cancer Institute (NCI)
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
National Cancer Institute (NCI)
Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel
Centre Hospitalier Universitaire de Nice
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
National Cancer Institute (NCI)
5fluorouracil for Advanced Photoaging
Federal University of São Paulo
Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control
Queen's University
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
National Cancer Institute (NCI)
ChemoSensMM
University of Wuerzburg
Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
Dermatologic Cooperative Oncology Group
Collaborative Ocular Melanoma Study (COMS)
National Eye Institute (NEI)
Vaccine Therapy for Patients With Stage III Melanoma
CancerVax Corporation
Vaccine Therapy for Patients With Stage IV Melanoma
CancerVax Corporation